Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Return on Assets (2016 - 2025)

Historic Return on Assets for Cytokinetics (CYTK) over the last 14 years, with Q3 2024 value amounting to 0.38%.

  • Cytokinetics' Return on Assets rose 3100.0% to 0.38% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.38%, marking a year-over-year increase of 3100.0%. This contributed to the annual value of 0.57% for FY2023, which is 2000.0% down from last year.
  • As of Q3 2024, Cytokinetics' Return on Assets stood at 0.38%, which was up 3100.0% from 0.46% recorded in Q2 2024.
  • Cytokinetics' 5-year Return on Assets high stood at 0.22% for Q1 2021, and its period low was 0.69% during Q3 2023.
  • Over the past 5 years, Cytokinetics' median Return on Assets value was 0.33% (recorded in 2022), while the average stood at 0.39%.
  • In the last 5 years, Cytokinetics' Return on Assets crashed by -4300bps in 2023 and then skyrocketed by 3100bps in 2024.
  • Quarter analysis of 5 years shows Cytokinetics' Return on Assets stood at 0.22% in 2020, then fell by -11bps to 0.24% in 2021, then crashed by -35bps to 0.33% in 2022, then plummeted by -104bps to 0.67% in 2023, then skyrocketed by 43bps to 0.38% in 2024.
  • Its last three reported values are 0.38% in Q3 2024, 0.46% for Q2 2024, and 0.64% during Q1 2024.